Oncology

Latest News

US map with stethoscope | Image credit: Andreas Prott – stock.adobe.com
5.5% of US Population Are Cancer Survivors, and the Number Is Growing

May 30th 2025

The most prevalent types are prostate cancer among men and breast cancer among women.

ASCO President Robin Zon, MD | Image credit: ASCO
March Toward More Tailored Treatments Continues at ASCO 2025

May 28th 2025

In the phase 3 IMforte trial, patients with extensive-stage small cell lung cancer experienced clinically meaningful benefits with maintenance lurbinectedin plus atezolizumab vs atezolizumab. | Image credit: appledesign - stock.adobe.com
Lurbinectedin Plus Atezolizumab Maintenance Shows Improved Survival vs Atezolizumab in SCLC

May 22nd 2025

AJMC Q&A with Eileen Peng, PharmD | Background image credit: ipopba - stock.adobe.com
The Role of Pharmacists Expands Beyond Dispensing for Novel Cancer Therapies: Eileen Peng, PharmD

May 21st 2025

Future validation studies with a larger sample size are warranted to ensure the technique will be useful in a clinical setting. | Image credit: Artur Wnorowski - stock.adobe.com
Novel, Noninvasive Skin Cancer Detection Method Shows Promise

May 18th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

This Week in Managed Care: July 30, 2016
July 30th 2016

This Week in Managed Care: July 30, 2016

This week, the top stories in managed care included the release of Medicare's Star ratings for hospital quality, a new proposal from CMS to require bundled payments for cardiac care, and an FDA panel recommended approving a continuous glucose monitoring system for dosing insulin.
Site Logo
July 29th 2016

Women Confident of Breast Cancer Treatment Decisions Following Online Support

Surabhi Dangi-Garimella, PhD
Sharing information of diagnosis and treatment decisions reassured women newly diagnosed with breast cancer of their health choices, according to a new study published in JAMA Oncology.
Site Logo
July 28th 2016

Combining Local Peripheral Treatment With Ipilimumab Doubles Survival in Melanoma

Surabhi Dangi-Garimella, PhD
A new study has found that combining ipilimumab with local peripheral treatments such as radiotherapy or electrochemotherapy can significantly better survival in patients with melanoma.
The Value of Patient Assistance Programs
July 28th 2016

The Value of Patient Assistance Programs

Do Accelerated Review and Narrow Indications Influence Payer Decisions?
July 28th 2016

Do Accelerated Review and Narrow Indications Influence Payer Decisions?

Clinical Pathways
July 28th 2016

Clinical Pathways

Appropriate Use of Companion Versus Complementary Diagnostics
July 28th 2016

Appropriate Use of Companion Versus Complementary Diagnostics

Influence of Biomarkers in Immunotherapy Treatment Decisions
July 28th 2016

Influence of Biomarkers in Immunotherapy Treatment Decisions

Payer Stance on Immunotherapy in Oncology Care
July 28th 2016

Payer Stance on Immunotherapy in Oncology Care

Importance of Patient Assistance Programs in Oncology
July 28th 2016

Importance of Patient Assistance Programs in Oncology

Do Oncologists Contemplate Patient Cost Sharing?
July 28th 2016

Do Oncologists Contemplate Patient Cost Sharing?

Value Benchmarks in Immuno-Oncology
July 28th 2016

Value Benchmarks in Immuno-Oncology

The Unmet Need in Immuno-Oncology and New Drug Approvals
July 28th 2016

The Unmet Need in Immuno-Oncology and New Drug Approvals

Health Plan Take on the Cancer Drug Approval Process and Surrogate Endpoints
July 28th 2016

Health Plan Take on the Cancer Drug Approval Process and Surrogate Endpoints

Improving Patient Access-Rapid Approval and Patient Assistance Programs
July 28th 2016

Improving Patient Access-Rapid Approval and Patient Assistance Programs

Combination Therapies: What Works Best for Immuno-Oncology?
July 28th 2016

Combination Therapies: What Works Best for Immuno-Oncology?

Payer Concerns With Including Novel Immunotherapies on Clinical Pathways
July 28th 2016

Payer Concerns With Including Novel Immunotherapies on Clinical Pathways

Combination Immunotherapies in Melanoma
July 28th 2016

Combination Immunotherapies in Melanoma

Understanding Immunotherapy Efficacy and Safety
July 28th 2016

Understanding Immunotherapy Efficacy and Safety

Clinical Pathway Consideration and Payer Decisions
July 28th 2016

Clinical Pathway Consideration and Payer Decisions

Safety and Efficacy of Targeted Therapy Versus Immunotherapy in Melanoma
July 28th 2016

Safety and Efficacy of Targeted Therapy Versus Immunotherapy in Melanoma

Clinician Concerns with Adopting Clinical Pathways
July 28th 2016

Clinician Concerns with Adopting Clinical Pathways

Health Plan Perspectives on Clinical Pathways
July 28th 2016

Health Plan Perspectives on Clinical Pathways

Clinical Pathways Should Keep Pace With New Data
July 28th 2016

Clinical Pathways Should Keep Pace With New Data

Distinguishing Between Companion and Complementary Diagnostic Tests
July 28th 2016

Distinguishing Between Companion and Complementary Diagnostic Tests

Health Plan Coverage of Diagnostic Tests for PD-L1 Expression
July 28th 2016

Health Plan Coverage of Diagnostic Tests for PD-L1 Expression

Predictive Biomarker Testing for Immunotherapy in Melanoma
July 28th 2016

Predictive Biomarker Testing for Immunotherapy in Melanoma

How Important Are Biomarkers for Treatment Selection in Lung Cancer?
July 28th 2016

How Important Are Biomarkers for Treatment Selection in Lung Cancer?

Early Biomarkers and Coverage Decisions in Immuno-Oncology
July 28th 2016

Early Biomarkers and Coverage Decisions in Immuno-Oncology

Immunotherapy in Oncology and the Role of the PD-L1 Biomarker
July 28th 2016

Immunotherapy in Oncology and the Role of the PD-L1 Biomarker

<1
...
949596979899100101102
...
185>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo